Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Gynecologic Oncology|April 1, 1989
Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group StudyJ T Thigpen, J A Blessing, H Homesley, et al.
Gynecologic Oncology|November 1, 1988
Hexamethylmelamine as first-line chemotherapy in the treatment of advanced or recurrent carcinoma of the endometrium: a phase II trial of the Gynecologic Oncology GroupJ T Thigpen, J A Blessing, H Ball, et al.
Gynecologic Oncology|September 1, 1986
Therapy of stage III (optimal) epithelial carcinoma of the ovary with melphalan or melphalan plus Corynebacterium parvum (a Gynecologic Oncology Group Study)S Gall, B Bundy, J Beecham, et al.
American Journal of Obstetrics and Gynecology|May 1, 1987
Positive groin lymph nodes in superficial squamous cell vulvar cancer. A Gynecologic Oncology Group StudyA Sedlis, H Homesley, B N Bundy, et al.
Gynecologic Oncology|August 12, 1998
Phase 2 trial of moderately high dose single agent mitoxantrone in platinum and paclitaxel-refractory ovarian cancerM Markman, S M Lichtman, H Homesley, et al.
Obstetrics and Gynecology|May 1, 1984
Multidrug treatment of advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group studyC J Cohen, H W Bruckner, G Deppe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancerG Kemp, P Rose, J Lurain, et al.
Gynecologic Oncology|April 1, 1996
Phase 1 trial of intraperitoneal AD-32 in gynecologic malignanciesM Markman, H Homesley, D A Norberts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1996
Phase I study of N-(phosphonacetyl)-L-aspartate with fluorouracil and with or without dipyridamole in patients with advanced cancerR A Fleming, R L Capizzi, H B Muss, et al.
Pageof 2